Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Differentiated Thyroid Cancer × surufatinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Endocrine 1

Conditions

Pancreatic Neoplasms 2 Neuroendocrine Tumors 2 Small Cell Lung Carcinoma 1 Pancreatic Cancer Metastatic 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neoplasm Metastasis 1 Differentiated Thyroid Cancer 1 Carcinoma, Non-Small-Cell Lung 1 Appendiceal Neoplasms 1 Advanced Biliary Tract Cancer 1

Interventions

surufatinib 1 pembrolizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05989425 2023-08-14

Surufatinib as Neoadjuvant Treatment for Locally Advanced or Metastatic Differentiated Thyroid Cancer

Fudan University

Phase 2 Recruiting

EndocrineHead & Neck

Differentiated Thyroid Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡